Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Creatinine is a metabolic byproduct of creatine phosphate, typically used as an endogenous marker for estimating glomerular filtration rate (GFR). In the specific clinical trial context of the Instituto Nacional de Cardiologia Ignacio Chavez, exogenous creatinine is administered as an oral 5-gram load to perform a "Tubular Stress Test." This test, often conducted alongside a furosemide stress test, is designed to evaluate the secretory capacity and residual functional reserve of the proximal tubules in patients with chronic kidney disease (CKD). By measuring the clearance of an exogenous creatinine load, researchers aim to provide a more detailed assessment of renal tubular health compared to standard GFR measurements, which primarily reflect glomerular filtration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on creatinine.